论文部分内容阅读
Lack of desirable release profile and rational drug combination are the major obstacles in successfully developing nano-sized codelivery system to reverse drug-resistance breast cancer.In this study,giusenoside Rh2 (G-Rh2) with the characteristic of amphipathy was applied as a p-glycoprotein (P-gp) inhibitor as well as anticancer therapeutic.